🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 36,209 shares @ $95.37
Total: $3.5M
Filed Oct 7, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@formdelta.bsky.social
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 36,209 shares @ $95.37
Total: $3.5M
Filed Oct 7, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 27,000 shares @ $92.31
Total: $2.5M
Filed Oct 7, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 24,000 shares @ $95.86
Total: $2.3M
Filed Oct 6, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 21,000 shares @ $96.81
Total: $2.0M
Filed Oct 4, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 72,000 shares @ $97.23
Total: $7.0M
Filed Oct 4, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 30,000 shares @ $96.22
Total: $2.9M
Filed Sep 16, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 34,000 shares @ $98.60
Total: $3.4M
Filed Sep 16, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 15,000 shares @ $96.09
Total: $1.4M
Filed Sep 14, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 34,000 shares @ $96.49
Total: $3.3M
Filed Sep 14, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@narrowit.bsky.socialBioNTech and OncoC4 Report Longer Survival With Gotistobart Updated stage-one data favored gotistobart over chemotherapy in previously treated squamous lung cancer, while the...
https://www.narrowit.com/news/biontech-oncoc4-gotistobart-survival-data-2026-09-14
#Biontech #BNTX #Oncoc4 #Gotistobart
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 20,500 shares @ $96.31
Total: $2.0M
Filed Sep 9, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 36,000 shares @ $97.78
Total: $3.5M
Filed Sep 7, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX
@formdelta.bsky.social🔴 $BNTX — Sahin Ugur, Chief Executive Officer
SOLD: 37,000 shares @ $99.20
Total: $3.7M
Filed Sep 7, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/BNTX